Trial · NCT02284191
Rapid Assessment of Potential Ischaemic Heart Disease With CTCA
NCT02284191, Not applicable, Completed, University of Edinburgh; results first posted 2024-08-21
3 sourcestrials-2026-11-12-0.5.0
Download JSON
Cite this record
ConductScience Library. Rapid Assessment of Potential Ischaemic Heart Disease With CTCA. Trials, record NCT02284191. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02284191
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Rapid Assessment of Potential Ischaemic Heart Disease With CTCA
- NCT number
- NCT02284191
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,749 participants, actual
- Lead sponsor
- University of Edinburgh
- Conditions
- Acute Coronary Syndrome
- Interventions
- CT Coronary Angiogram
- First posted
- 2014-11-05
- Last updated
- 2024-08-21
- Results first posted
- 2024-08-21
Source ClinicalTrials.gov
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. | 1 year (post randomisation) | Number of participants categorised as having primary outcome event - all-cause death or subsequent non-fatal myocardial infarction (type 1 or 4b) at one year (post randomisation), measured as time to first such event. Myocardial infarction 'type' was defined according to the most recent Universal Definition (1). and was adjudicated independently by two cardiologists blinded to the intervention and the categorisation added to the study database. |
| Secondary | Coronary Heart Disease Death or Subsequent Non-fatal MI | 1 year (post randomisation) | Number of participants with coronary heart disease death or subsequent non-fatal myocardial infarction, one year after randomisation. |
| Secondary | Cardiovascular Disease Death or Subsequent Non-fatal MI | 1 year (post randomisation) | Number of participants categorised as having cardiovascular disease death or subsequent non-fatal myocardial infarction, one year after randomisation |
| Secondary | Subsequent Non-fatal MI | 1 year (post randomisation) | Number of participants with subsequent non-fatal myocardial infarction, at one year post-randomisation. |
| Secondary | Coronary Heart Disease Death | 1 year (post randomisation) | Number of participants with Coronary Heart Disease deaths, one year after randomisation |
| Secondary | Cardiovascular Death | 1 year (post-randomisation) | Number of participants with cardiovascular death, one year after randomisation |
| Secondary | All-cause Death | 1 year (post-randomisation) | Number of participants with "all-cause" death, one year post-randomisation |
| Secondary | Coronary Heart Disease (CHD) Death or Subsequent Non-fatal MI (Type 1 or 4b) | 1 year (post randomisation) | Number of participants with Coronary heart disease death or subsequent non-fatal myocardial infarction (type 1 or 4b), one year after randomisation |
| Secondary | Subsequent Non-fatal MI (Type 1 or 4b) | 1 year (post-randomisation) | Number of participants with subsequent non-fatal myocardial infarction (type 1 or 4b), one year post randomisation |
| Secondary | Non-cardiovascular Death | 1 year (post-randomisation) | Number of participants with non-cardiovascular deaths, one year post-randomisation |
1 to 10 of 19Source ClinicalTrials.gov
See all 19 registered outcomesOutcomes19
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. | 1 year (post randomisation) | All randomised participants | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Coronary Heart Disease Death or Subsequent Non-fatal MI | 1 year (post randomisation) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Cardiovascular Disease Death or Subsequent Non-fatal MI | 1 year (post randomisation) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Subsequent Non-fatal MI | 1 year (post randomisation) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Coronary Heart Disease Death | 1 year (post randomisation) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Cardiovascular Death | 1 year (post-randomisation) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | All-cause Death | 1 year (post-randomisation) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Coronary Heart Disease (CHD) Death or Subsequent Non-fatal MI (Type 1 or 4b) | 1 year (post randomisation) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Subsequent Non-fatal MI (Type 1 or 4b) | 1 year (post-randomisation) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Non-cardiovascular Death | 1 year (post-randomisation) | Participants | COUNT_OF_PARTICIPANTS |
1 to 10 of 19Source ClinicalTrials.gov
See all 19 outcomesResults by group37
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. | CT Coronary Angiogram | 51 | Participants | ||
| All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. | Standard Care | 53 | Participants | ||
| Coronary Heart Disease Death or Subsequent Non-fatal MI | CT Coronary Angiogram | 47 | Participants | ||
| Coronary Heart Disease Death or Subsequent Non-fatal MI | Standard Care | 45 | Participants | ||
| Cardiovascular Disease Death or Subsequent Non-fatal MI | CT Coronary Angiogram | 48 | Participants | ||
| Cardiovascular Disease Death or Subsequent Non-fatal MI | Standard Care | 46 | Participants | ||
| Subsequent Non-fatal MI | CT Coronary Angiogram | 39 | Participants | ||
| Subsequent Non-fatal MI | Standard Care | 40 | Participants | ||
| Coronary Heart Disease Death | CT Coronary Angiogram | 11 | Participants | ||
| Coronary Heart Disease Death | Standard Care | 6 | Participants |
1 to 10 of 37Source ClinicalTrials.gov
See all 37 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | CTCA Plus Standard Care | 877 | |
| Overall Study | STARTED | Standard Care | 871 | |
| Overall Study | COMPLETED | CTCA Plus Standard Care | 875 | |
| Overall Study | COMPLETED | Standard Care | 868 | |
| Overall Study | NOT COMPLETED | CTCA Plus Standard Care | 2 | |
| Overall Study | NOT COMPLETED | Standard Care | 3 |
Source ClinicalTrials.gov
Adverse events14
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | IV cannula issue | Surgical and medical procedures | CT Coronary Angiogram | 3 | 877 | 3 |
| other | IV cannula issue | Surgical and medical procedures | Standard Care | 0 | 871 | 0 |
| serious | Readmission with non-cardiac condition | General disorders | CT Coronary Angiogram | 6 | 877 | 6 |
| serious | Readmission with non-cardiac condition | General disorders | Standard Care | 2 | 871 | 2 |
| serious | Readmission with chest pain - not CHD related | General disorders | CT Coronary Angiogram | 2 | 877 | 2 |
| serious | Readmission with chest pain - not CHD related | General disorders | Standard Care | 4 | 871 | 4 |
| serious | Readmission with chest pain - CHD related | General disorders | CT Coronary Angiogram | 3 | 877 | 3 |
| serious | Readmission with chest pain - CHD related | General disorders | Standard Care | 2 | 871 | 2 |
| serious | Readmission with chest pain - unclear | General disorders | CT Coronary Angiogram | 1 | 877 | 1 |
| serious | Readmission with chest pain - unclear | General disorders | Standard Care | 2 | 871 | 2 |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 adverse eventsAdverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | CT Coronary Angiogram | 19 | 877 |
| Total, all-cause mortality | Standard Care | 17 | 871 |
| Total, other adverse events | CT Coronary Angiogram | 3 | 877 |
| Total, other adverse events | Standard Care | 0 | 871 |
| Total, serious adverse events | CT Coronary Angiogram | 18 | 877 |
| Total, serious adverse events | Standard Care | 10 | 871 |
Source ClinicalTrials.gov
Papers8
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons19
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| CT Coronary Angiogram vs Standard Care: Invasive Coronary Angiography | Trial comparisons |
| CT Coronary Angiogram vs Standard Care: Subsequent Non-fatal MI (Type 1 or 4b) | Trial comparisons |
| CT Coronary Angiogram vs Standard Care: Coronary Revascularisation | Trial comparisons |
| CT Coronary Angiogram vs Standard Care: Coronary Heart Disease Death | Trial comparisons |
| CT Coronary Angiogram vs Standard Care: Discharged on Preventative Treatment or Alteration in Dosage of Preventative Treatment During Index Hospitalisation | Trial comparisons |
| CT Coronary Angiogram vs Standard Care: Cardiovascular Disease Death or Subsequent Non-fatal MI | Trial comparisons |
| CT Coronary Angiogram vs Standard Care: Coronary Heart Disease Death or Subsequent Non-fatal MI | Trial comparisons |
| CT Coronary Angiogram vs Standard Care: Representation or Rehospitalisation With Suspected ACS/ Recurrent Chest Pain After Index Hospitalisation | Trial comparisons |
| CT Coronary Angiogram vs Standard Care: All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. | Trial comparisons |
| CT Coronary Angiogram vs Standard Care: Cardiovascular Death | Trial comparisons |
1 to 10 of 19
See all 19 trial comparisonsTests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02284191
GET https://conductscience.org/api/trials/v1/NCT02284191/results?page=2